Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
8Customers
3Debt Items
6Related Chains
Source-Backed Evidence Depth
SeaStar Medical Holding Corporation (ICU) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
16Total relationships
2Distinct source URLs
7High confidence
0.751Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
SeaStar Medical Holding Corporation Suppliers
Ticker
Name
Confidence
Evidence
FRESENIUS-MEDICAL-CARE-NORTH-AMERICA
FRESENIUS-MEDICAL-CARE-NORTH-AMERICA
92%
Fresenius Medical Care North America ("FMCNA") is the current supplier of the cartridges used in our SCD.
FRESENIUS-USA-MARKETING-INC
FRESENIUS-USA-MARKETING-INC
92%
In March 2022, we entered into a supply agreement (the "Supply Agreement") with an FMCNA affiliate, Fresenius USA Marketing, Inc. ("FUSA"), to supply certain cartridges at an agreed amount per case f…
LINCOLN-PARK-CAPITAL-FUND-LLC
LINCOLN-PARK-CAPITAL-FUND-LLC
90%
the Company agreed to issue to Lincoln Park 23,641 shares of the Company’s Common Stock, valued at approximately $ 0.3 million on the date of issuance
Reciprocal relationship from LMFA graph: Reciprocal relationship from ICU graph: Reciprocal relationship from LMFA graph: uded in “Professional Fees” in the consolidated statements of operations for …
SeaStar Medical Holding Corporation Customers
Ticker
Name
Confidence
Evidence
FRESENIUS-MEDICAL-CARE-HOLDINGS-INC
FRESENIUS-MEDICAL-CARE-HOLDINGS-INC
62%
ife. SCD Therapy for Pediatric Patients We are currently commercializing our first product, QUELIMMUNE, under an HDE that was approved by the FDA on February 21, 2024. QUELIMMUNE is currently the onl…
FRESENIUS-USA-MARKETING-INC
FRESENIUS-USA-MARKETING-INC
62%
n cardiac death. Both acute and chronic inflammation and its cellular immunologic effector, the activated monocyte, are central to the accelerated cardiovascular disease in patients with chronic end-…
LEGACY-SEASTAR-INC
LEGACY-SEASTAR-INC
62%
ng approximately 0.9 million shares of the Company's common stock. 90 Table of Contents SeaStar Medical Holding Corporation Notes to the Consolidated Financial Statements Standby Equity Purchase Agre…
LINCOLN-PARK-CAPITAL-FUND-LLC
LINCOLN-PARK-CAPITAL-FUND-LLC
62%
ng approximately 0.9 million shares of the Company's common stock. 90 Table of Contents SeaStar Medical Holding Corporation Notes to the Consolidated Financial Statements Standby Equity Purchase Agre…
LINCOLN-PARK-CAPITAL-LLC
LINCOLN-PARK-CAPITAL-LLC
62%
Item 1A, “Risk Factors,” for additional information. Results of Operations Comparison of the Three Months Ended March 31, 2026 to the Three Months Ended March 31, 2025 The following table sets forth …
LMF-ACQUISITION-OPPORTUNITIES-INC
LMF-ACQUISITION-OPPORTUNITIES-INC
62%
present a risk to health. Some changes to an approved PMA or HDE device, including changes in indications, labeling or manufacturing processes or facilities, require submission and FDA approval of a …
LMF-MERGER-SUB-INC
LMF-MERGER-SUB-INC
62%
present a risk to health. Some changes to an approved PMA or HDE device, including changes in indications, labeling or manufacturing processes or facilities, require submission and FDA approval of a …
MEDICAL-HOLDING-CORPORATION
MEDICAL-HOLDING-CORPORATION
62%
aStar Medical Holding Corporation Notes to the Consolidated Financial Statements Note 12. Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to…
SeaStar Medical Holding Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
ICU-DEBT-10177
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
ICU-DEBT-10176
Warrants outstanding: 21682
90%
xbrl warrant detail from xbrl 2025-12-31.
ICU-DEBT
Debt stack $331,000
90%
Market cache reports total debt of $331,000.
SeaStar Medical Holding Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for SeaStar Medical Holding Corporation.
SeaStar Medical Holding Corporation Ownership
Holder
Name
Confidence
Evidence
ICU-OWNER-GOLDMAN-SACHS-GROUP-INC
GOLDMAN SACHS GROUP INC
90%
13F overlay lists GOLDMAN SACHS GROUP INC as top holder; 3 tracked holders.
SeaStar Medical Holding Corporation Extended Supply Chain Network
